Radiation-induced intestinal damage: latest molecular and clinical developments

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104(6), 1129–1137 (2005).
  MedlineGoogle Scholar
• 2. Miller KD, Nogueira L, Mariotto AB et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69(5), 363–385 (2019).
  MedlineGoogle Scholar
• 3. Kingham TP, Wong SL. Global surgical oncology: addressing the global surgical oncology disease burden. Ann. Surg. Oncol. 22(3), 708–709 (2015).
  MedlineGoogle Scholar
• 4. Martinel Lamas DJ, Carabajal E, Prestifilippo JP et al. Protection of radiation-induced damage to the hematopoietic system, small intestine and salivary glands in rats by JNJ7777120 compound, a histamine H4 ligand. PLoS ONE 8(7), e69106 (2013).
  MedlineGoogle Scholar
• 5. Bryant AK, Banegas MP, Martinez ME, Mell LK, Murphy JD. Trends in radiation therapy among cancer survivors in the United States, 2000-2030. Cancer Epidemiol. Biomarkers Prev. 26(6), 963–970 (2017).
  MedlineGoogle Scholar
• 6. Chen SW, Liang JA, Yang SN et al. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer. Gynecol. Oncol. 95(1), 208–214 (2004).
  MedlineGoogle Scholar
• 7. Wu D, Han R, Deng S et al. Protective effects of flagellin A N/C against radiation-induced NLR pyrin domain containing 3 inflammasome-dependent pyroptosis in intestinal cells. Int. J. Radiat. Oncol. Biol. Phys. 101(1), 107–117 (2018).
  Medline CASGoogle Scholar
• 8. Sun YW, Zhang YY, Ke XJ, Wu XJ, Chen ZF, Chi P. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-beta1/Smad/CTGF signaling pathway. Eur. J. Pharmacol. 822, 199–206 (2018).
  Medline CASGoogle Scholar
• 9. Riehl TE, Alvarado D, Ee X et al. Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells. Gut 68 (6), 1003–1013 (2018).
  MedlineGoogle Scholar
• 10. Li G, Cheng K, Zhao Z, Wang J, Zhu W, Li J. [Treatment of 21 cases of chronic radiation intestinal injury by staging ileostomy and closure operation]. Zhonghua Wei Chang Wai Ke Za Zhi 21(7), 772–778 (2018).
  MedlineGoogle Scholar
• 11. Kim BH, Jung HW, Seo SH, Shin H, Kwon J, Suh JM. Synergistic actions of FGF2 and bone marrow transplantation mitigate radiation-induced intestinal injury. Cell Death Dis. 9(3), 383 (2018).
  MedlineGoogle Scholar
• 12. Suman S, Kumar S, Moon BH, Fornace AJ Jr, Kallakury BVS, Datta K. Increased transgenerational intestinal tumorigenesis in offspring of ionizing radiation exposed parent APC(1638N/+) Mice. J. Cancer 8(10), 1769–1773 (2017).
  MedlineGoogle Scholar
• 13. Eltahawy NA, Elsonbaty SM, Abunour S, Zahran WE. Synergistic effect of aluminum and ionizing radiation upon ultrastructure, oxidative stress and apoptotic alterations in Paneth cells of rat intestine. Environ. Sci. Pollut. Res. Int. 24(7), 6657–6666 (2017).
  Medline CASGoogle Scholar
• 14. Suman S, Kallakury BV, Fornace AJ Jr. Datta K. Protracted upregulation of leptin and IGF1 is associated with activation of PI3K/Akt and JAK2 pathway in mouse intestine after ionizing radiation exposure. Int. J. Biol. Sci. 11(3), 274–283 (2015).
  Medline CASGoogle Scholar
• 15. Zhang C, Ni J, Li BL et al. CpG-oligodeoxynucleotide treatment protects against ionizing radiation-induced intestine injury. PLoS ONE 8(6), e66586 (2013).
  Medline CASGoogle Scholar
• 16. Matsuu-Matsuyama M, Nakashima M, Shichijo K, Okaichi K, Nakayama T, Sekine I. Basic fibroblast growth factor suppresses radiation-induced apoptosis and TP53 pathway in rat small intestine. Radiat. Res. 174(1), 52–61 (2010).
  Medline CASGoogle Scholar
• 17. Yeh MH, Chang YH, Tsai YC et al. Bone marrow derived macrophages fuse with intestine stromal cells and contribute to chronic fibrosis after radiation. Radiother. Oncol. 119(2), 250–258 (2016).
  Medline CASGoogle Scholar
• 18. Jahnson S, Christofferson RH, Gerdin B. Reduced mucosal perianastomotic capillary density in rat small intestine with chronic radiation damage. Radiat. Res. 150(5), 542–548 (1998).
  Medline CASGoogle Scholar
• 19. Takemura N, Kurashima Y, Mori Y et al. Eosinophil depletion suppresses radiation-induced small intestinal fibrosis. Sci. Transl. Med. 10(429), 0333 (2018).
  Google Scholar
• 20. Olopade FA, Norman A, Blake P et al. A modified inflammatory bowel disease questionnaire and the vaizey incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br. J. Cancer 92(9), 1663–1670 (2005).
  Medline CASGoogle Scholar
• 21. Kalita B, Ranjan R, Gupta ML. Combination treatment of podophyllotoxin and rutin promotes mouse Lgr5(+ve) intestinal stem cells survival against lethal radiation injury through Wnt signaling. Apoptosis doi:10.1007/s10495-019-01519-x (2019).
  MedlineGoogle Scholar
• 22. Kuo B, Szabo E, Lee SC et al. The LPA2 receptor agonist Radioprotectin-1 spares Lgr5-positive intestinal stem cells from radiation injury in murine enteroids. Cell. Signal. 51, 23–33 (2018).
  Medline CASGoogle Scholar
• 23. Boyne DJ, O'Sullivan DE, Olij BF, King WD, Friedenreich CM, Brenner DR. Physical activity, global DNA methylation, and breast cancer risk: a systematic literature review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 27(11), 1320–1331 (2018).
  Medline CASGoogle Scholar
• 24. Kim JS, Han NK, Kim SH, Lee HJ. Silibinin attenuates radiation-induced intestinal fibrosis and reverses epithelial-to-mesenchymal transition. Oncotarget 8(41), 69386–69397 (2017).
  MedlineGoogle Scholar
• 25. Kim CK, Yang VW, Bialkowska AB. The role of intestinal stem cells in epithelial regeneration following radiation-induced gut injury. Curr. Stem Cell Rep. 3(4), 320–332 (2017). •• Explores the regenerative capacity and mechanisms of various populations of intestinal stem cells in response to ionizing radiation.
  Medline CASGoogle Scholar
• 26. Chen W, Ju S, Lu T et al. Directional delivery of RSPO1 by mesenchymal stem cells ameliorates radiation-induced intestinal injury. Cytokine 95, 27–34 (2017).
  Medline CASGoogle Scholar
• 27. Bhanja P, Norris A, Gupta-Saraf P, Hoover A, Saha S. BCN057 induces intestinal stem cell repair and mitigates radiation-induced intestinal injury. Stem Cell Res. Ther. 9(1), 26 (2018).
  Medline CASGoogle Scholar
• 28. Liang Y, Zhou H, Yao Y et al. 12-O-tetradecanoylphorbol-13-acetate (TPA) increases murine intestinal crypt stem cell survival following radiation injury. Oncotarget 8(28), 45566–45576 (2017).
  MedlineGoogle Scholar
• 29. Ahmadzai AA, Patel Ii, Veronesi G et al. Determination using synchrotron radiation-based Fourier transform infrared microspectroscopy of putative stem cells in human adenocarcinoma of the intestine: corresponding benign tissue as a template. Appl. Spectrosc. 68(8), 812–822 (2014).
  Medline CASGoogle Scholar
• 30. Gracz AD, Fuller MK, Wang F et al. Brief report: CD24 and CD44 mark human intestinal epithelial cell populations with characteristics of active and facultative stem cells. Stem Cells 31(9), 2024–2030 (2013).
  Medline CASGoogle Scholar
• 31. Umar S. Intestinal stem cells. Curr. Gastroenterol. Rep. 12(5), 340–348 (2010).
  MedlineGoogle Scholar
• 32. Meran L, Baulies A, Li VSW. Intestinal stem cell niche: the extracellular matrix and cellular components. Stem Cells Int. 2017, 11 (2017).
  Google Scholar
• 33. Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2(3), 203–212 (2006).
  Medline CASGoogle Scholar
• 34. François A, Milliat F, Guipaud O, Benderitter M. Inflammation and immunity in radiation damage to the gut mucosa. Biomed. Res. Int. 2013, 123241–123241 (2013). • Focuses on what has been observed in the healthy gut and what needs to be done concerning the immunoinflammatory response after localized radiation exposure.
  MedlineGoogle Scholar
• 35. Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother. Oncol. 61(3), 223–231 (2001).
  Medline CASGoogle Scholar
• 36. Shukla PK, Gangwar R, Manda B et al. Rapid disruption of intestinal epithelial tight junction and barrier dysfunction by ionizing radiation in mouse colon in vivo: protection by N-acetyl-l-cysteine. Am. J. Physiol. Gastrointest. Liver Physiol. 310(9), G705–G715 (2016).
  MedlineGoogle Scholar
• 37. Kim ND, Luster AD. The role of tissue resident cells in neutrophil recruitment. Trends Immunol. 36(9), 547–555 (2015).
  Medline CASGoogle Scholar
• 38. Young MA, Daly CS, Taylor E, James R, Clarke AR, Reed KR. Subtle deregulation of the Wnt-signaling pathway through loss of Apc2 reduces the fitness of intestinal stem cells. Stem Cells 36(1), 114–122 (2018).
  Medline CASGoogle Scholar
• 39. Katoh M, Katoh M. WNT antagonist, DKK2, is a notch signaling target in intestinal stem cells: augmentation of a negative regulation system for canonical WNT signaling pathway by the Notch-DKK2 signaling loop in primates. Int. J. Mol. Med. 19(1), 197–201 (2007).
  Medline CASGoogle Scholar
• 40. Peck BC, Mah AT, Pitman WA, Ding S, Lund PK, Sethupathy P. Functional transcriptomics in diverse intestinal epithelial cell types reveals robust microRNA sensitivity in intestinal stem cells to microbial status. J. Biol. Chem. 292(7), 2586–2600 (2017).
  Medline CASGoogle Scholar
• 41. Foronda D, Weng R, Verma P, Chen YW, Cohen SM. Coordination of insulin and Notch pathway activities by microRNA miR-305 mediates adaptive homeostasis in the intestinal stem cells of the Drosophila gut. Genes Dev. 28(21), 2421–2431 (2014).
  MedlineGoogle Scholar
• 42. Han NK, Jeong YJ, Pyun BJ, Lee YJ, Kim SH, Lee HJ. Geranylgeranylacetone ameliorates intestinal radiation toxicity by preventing endothelial cell dysfunction. Int. J. Mol. Sci. 18(10), 2103 (2017).
  Google Scholar
• 43. Wang J, Zheng H, Ou X, Fink LM, Hauer-Jensen M. Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am. J. Pathol. 160(6), 2063–2072 (2002).
  Medline CASGoogle Scholar
• 44. Li Y, Kong S, Yang F, Xu W. Protective effects of 2-amino-5,6-dihydro-4h-1,3-thiazine and its derivative against radiation-induced hematopoietic and intestinal injury in mice. Int. J. Mol. Sci. 19(5), 1530 (2018).
  Google Scholar
• 45. Du B, Yuan J, Ren ZQ et al. Effect of different doses of radiation on intestinal injury in NOD/SCID Mice. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 40(1), 7–12 (2018). • Studies the effect of different doses of radiation on intestinal injury, with an attempt to find the optimal radiation dose for establishing intestinal injury models in NOD/SCID mice.
  MedlineGoogle Scholar
• 46. Suman S, Kumar S, Moon BH, Fornace AJ Jr. Datta K. Low and high dose rate heavy ion radiation-induced intestinal and colonic tumorigenesis in APC(1638N/+) mice. Life Sci. Space Res. (Amst.) 13, 45–50 (2017).
  MedlineGoogle Scholar
• 47. Lee C, Shim S, Jang H et al. Human umbilical cord blood-derived mesenchymal stromal cells and small intestinal submucosa hydrogel composite promotes combined radiation-wound healing of mice. Cytotherapy 19(9), 1048–1059 (2017).
  Medline CASGoogle Scholar
• 48. Klochkova SV, Kvaratskheliya AG, Alekseeva NT, Nikityuk DB. Regeneration potential of lymphoid tissue of small intestine in mice after exposure to low-intensity radiation. Bull. Exp. Biol. Med. 164(2), 214–217 (2017).
  Medline CASGoogle Scholar
• 49. Jeong BK, Song JH, Jeong H et al. Effect of alpha-lipoic acid on radiation-induced small intestine injury in mice. Oncotarget 7(12), 15105–15117 (2016).
  MedlineGoogle Scholar
• 50. Grubskaia LV, Voitsitskii VM, Khizhniak SV. [The effect of ionizing radiation with low dose rate on the state of electron transfer chain of enterocyte mitochondria of rat small intestine]. Ukr. Biokhim. Zh. (1999) 84(1), 45–52 (2012).
  Medline CASGoogle Scholar
• 51. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol. 8(11), 1007–1017 (2007).
  MedlineGoogle Scholar
• 52. Kumar S, Suman S, Fornace AJ Jr., Datta K. Space radiation triggers persistent stress response, increases senescent signaling, and decreases cell migration in mouse intestine. Proc. Natl Acad. Sci. USA 115(42), E9832–E9841 (2018).
  Medline CASGoogle Scholar
• 53. Lim YB, Pyun BJ, Lee HJ, Jeon SR, Jin YB, Lee YS. Proteomic identification of radiation response markers in mouse intestine and brain. Proteomics 11(7), 1254–1263 (2011).
  Medline CASGoogle Scholar
• 54. Wang J, Zheng H, Kulkarni A, Ou X, Hauer-Jensen M. Regulation of early and delayed radiation responses in rat small intestine by capsaicin-sensitive nerves. Int. J. Radiat. Oncol. Biol. Phys. 64(5), 1528–1536 (2006).
  Medline CASGoogle Scholar
• 55. Stenson WF. Prostaglandins and the epithelial response to radiation injury in the intestine. Curr. Opin. Gastroenterol. 20(2), 61–64 (2004).
  Medline CASGoogle Scholar
• 56. Miyoshi-Imamura T, Kakinuma S, Kaminishi M et al. Unique characteristics of radiation-induced apoptosis in the postnatally developing small intestine and colon of mice. Radiat. Res. 173(3), 310–318 (2010).
  Medline CASGoogle Scholar
• 57. Houchen CW, Sturmoski MA, Anant S, Breyer RM, Stenson WF. Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 284(3), G490–G498 (2003).
  Medline CASGoogle Scholar
• 58. Moon C, Ahn K, Kim J et al. Eutigoside C attenuates radiation-induced crypt injury in the mouse intestine. Phytother. Res. 24(6), 840–845 (2010).
  Medline CASGoogle Scholar
• 59. Dolzhanov A, Ushakov IB. [Mitotic activity of epithelium in crypts of rats' empty intestine and tissue basophils in the event of intestinal syndrome of radiation disease treated with poly-radio-modification]. Aviakosm. Ekolog. Med. 35(4), 66–69 (2001).
  MedlineGoogle Scholar
• 60. Lee MG, Freeman AR, Roos DE, Milner AD, Borg MF. Randomized double-blind trial of amifostine versus placebo for radiation-induced xerostomia in patients with head and neck cancer. J. Med. Imaging Radiat. Oncol. 63(1), 142–150 (2019).
  MedlineGoogle Scholar
• 61. Huang B, He T, Yao Q et al. Amifostine suppresses the side effects of radiation on BMSCs by promoting cell proliferation and reducing ROS production. Stem Cells Int. 2019, 8749090 (2019).
  MedlineGoogle Scholar
• 62. Koukourakis MI, Giatromanolaki A, Fylaktakidou K et al. Amifostine protects mouse liver against radiation-induced autophagy blockage. Anticancer Res. 38(1), 227–238 (2018).
  Medline CASGoogle Scholar
• 63. Cook JA, Naz S, Anver MR et al. Cancer incidence in C3H mice protected from lethal total-body radiation after amifostine. Radiat. Res. 189(5), 490–496 (2018).
  Medline CASGoogle Scholar
• 64. Can B, Atilgan R, Pala S, Kuloglu T, Kiray S, Ilhan N. Examination of the effect of ovarian radiation injury induced by hysterosalpingography on ovarian proliferating cell nuclear antigen and the radioprotective effect of amifostine: an experimental study. Drug Des. Devel. Ther. 12, 1491–1500 (2018).
  Medline CASGoogle Scholar
• 65. Ueno M, Matsumoto S, Matsumoto A et al. Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. J. Clin. Biochem. Nutr. 60(3), 151–155 (2017).
  Medline CASGoogle Scholar
• 66. Aktoz T, Caloglu M, Yurut-Caloglu V et al. Histopathological and biochemical comparisons of the protective effects of amifostine and l-carnitine against radiation-induced acute testicular toxicity in rats. Andrologia 49(9), e12754 (2017).
  Google Scholar
• 67. Cakmak G, Severcan M, Zorlu F, Severcan F. Structural and functional damages of whole body ionizing radiation on rat brain homogenate membranes and protective effect of amifostine. Int. J. Radiat. Biol. 92(12), 837–848 (2016).
  Medline CASGoogle Scholar
• 68. Kouloulias VE, Kouvaris JR, Pissakas G et al. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Int. J. Radiat. Oncol. Biol. Phys. 62(2), 486–493 (2005).
  Medline CASGoogle Scholar
• 69. Katsanos KH, Briasoulis E, Tsekeris P et al. Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis. J. Exp. Clin. Cancer Res. 29(1), 68 (2010).
  MedlineGoogle Scholar
• 70. Kouvaris J, Kouloulias V, Malas E et al. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy. Strahlenther. Onkol. 179(3), 167–174 (2003).
  MedlineGoogle Scholar
• 71. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 51(1), 261–266 (2001).
  Medline CASGoogle Scholar
• 72. Sterzing F, Engenhart-Cabillic R, Flentje M, Debus J. Image-guided radiotherapy: a new dimension in radiation oncology. Dtsch. Arztebl. Int. 108(16), 274–280 (2011).
  MedlineGoogle Scholar
• 73. Hugo GD, Yan D, Liang J. Population and patient-specific target margins for 4D adaptive radiotherapy to account for intra-and inter-fraction variation in lung tumour position. Phys. Med. Biol. 52(1), 257 (2006).
  MedlineGoogle Scholar
• 74. Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int. J. Radiat. Oncol. Biol. Phys. 76(Suppl. 3), S123–S129 (2010).
  MedlineGoogle Scholar
• 75. Wiesendanger-Wittmer EM, Sijtsema NM, Muijs CT, Beukema JC. Systematic review of the role of a belly board device in radiotherapy delivery in patients with pelvic malignancies. Radiother. Oncol. 102(3), 325–334 (2012).
  MedlineGoogle Scholar
• 76. Buchi KN, Moore JG, Hrushesky WJ, Sothern RB, Rubin NH. Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 101(2), 410–415 (1991).
  Medline CASGoogle Scholar
• 77. Aluwini S, Pos F, Schimmel E et al. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. Lancet Oncol. 16(3), 274–283 (2015).
  MedlineGoogle Scholar
• 78. Arcangeli G, Saracino B, Gomellini S et al. A prospective Phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 78(1), 11–18 (2010).
  MedlineGoogle Scholar
• 79. Koontz BF, Bossi A, Cozzarini C, Wiegel T, D'amico A. A systematic review of hypofractionation for primary management of prostate cancer. Eur. Urol. 68(4), 683–691 (2015).
  MedlineGoogle Scholar
• 80. Yavas C, Yavas G, Celik E et al. Beta-hydroxy-beta-methyl-butyrate, L-glutamine, and L-arginine supplementation improves radiation-induce acute intestinal toxicity. J. Diet. Suppl. 16 (5), 576–591 (2018).
  MedlineGoogle Scholar
• 81. Vidal-Casariego A, Calleja-Fernandez A, De Urbina-Gonzalez JJ, Cano-Rodriguez I, Cordido F, Ballesteros-Pomar MD. Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial. JPEN J. Parenter. Enteral Nutr. 38(2), 205–213 (2014).
  MedlineGoogle Scholar
• 82. Shim S, Jang HS, Myung HW et al. Rebamipide ameliorates radiation-induced intestinal injury in a mouse model. Toxicol. Appl. Pharmacol. 329, 40–47 (2017).
  Medline CASGoogle Scholar
• 83. Banerjee S, Shah SK, Melnyk SB, Pathak R, Hauer-Jensen M, Pawar SA. Cebpd is essential for gamma-tocotrienol mediated protection against radiation-induced hematopoietic and intestinal injury. Antioxidants (Basel) 7(4), 55 (2018).
  Google Scholar
• 84. Hille A, Christiansen H, Pradier O et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol. 181(9), 606–614 (2005).
  MedlineGoogle Scholar
• 85. Thotala D, Chetyrkin S, Hudson B, Hallahan D, Voziyan P, Yazlovitskaya E. Pyridoxamine protects intestinal epithelium from ionizing radiation-induced apoptosis. Free Radic. Biol. Med. 47(6), 779–785 (2009).
  Medline CASGoogle Scholar
• 86. Roche M, Neti PV, Kemp FW et al. Radiation-induced reductions in transporter mRNA levels parallel reductions in intestinal sugar transport. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298(1), R173–R182 (2010).
  Medline CASGoogle Scholar
• 87. Roche M, Kemp FW, Agrawal A et al. Marked changes in endogenous antioxidant expression precede vitamin A-, C-, and E-protectable, radiation-induced reductions in small intestinal nutrient transport. Free Radic. Biol. Med. 50(1), 55–65 (2011).
  Medline CASGoogle Scholar
• 88. Sato T, Kinoshita M, Yamamoto T et al. Treatment of irradiated mice with high-dose ascorbic acid reduced lethality. PloS ONE 10(2), e0117020 (2015).
  MedlineGoogle Scholar
• 89. Kennedy M, Bruninga K, Mutlu EA, Losurdo J, Choudhary S, Keshavarzian A. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am. J. Gastroenterol. 96(4), 1080–1084 (2001).
  Medline CASGoogle Scholar
• 90. Khayyal MT, Kreuter MH, Kemmler M, Altmann P, Abdel-Naby DH, El-Ghazaly MA. Effect of a chamomile extract in protecting against radiation-induced intestinal mucositis. Phytother. Res. doi:10.1002/ptr.6263 (2019) (Epub ahead of print).
  MedlineGoogle Scholar
• 91. Mangoni M, Sottili M, Gerini C et al. A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. United European Gastroenterol. J. 5(2), 218–226 (2017).
  Medline CASGoogle Scholar
• 92. Van De Wetering FT, Verleye L, Andreyev HJ et al. Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis. Cochrane Database Syst. Rev. 4, Cd003455 (2016).
  MedlineGoogle Scholar
• 93. Wang J, Boerma M, Fu Q, Kulkarni A, Fink LM, Hauer-Jensen M. Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism. Int. J. Radiat. Oncol. Biol. Phys. 68(5), 1483–1490 (2007).
  Medline CASGoogle Scholar
• 94. Wedlake LJ, Silia F, Benton B et al. Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. Eur. J. Cancer 48(14), 2117–2124 (2012).
  Medline CASGoogle Scholar
• 95. Cheng Y, Dong Y, Hou Q et al. The protective effects of XH-105 against radiation-induced intestinal injury. J. Cell. Mol. Med. 23(3), 2238–2247 (2019).
  Medline CASGoogle Scholar
• 96. Jahraus CD, Bettenhausen D, Malik U, Sellitti M, St Clair WH. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 63(5), 1483–1487 (2005).
  Medline CASGoogle Scholar
• 97. Elshawi OE, Nabeel AI. Modulatory effect of a new benzopyran derivative via COX-2 blocking and down regulation of NF-kappaB against gamma-radiation induced- intestinal inflammation. J. Photochem. Photobiol. B Biol. 192, 90–96 (2019).
  Medline CASGoogle Scholar
• 98. Gu J, Liu S, Mu N et al. A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury. J. Control Release 260, 32–45 (2017).
  Medline CASGoogle Scholar
• 99. Kligler B, Cohrssen A. Probiotics. Am. Fam. Physician 78(9), 1073–1078 (2008).
  MedlineGoogle Scholar
• 100. Stacey R, Green JT. Radiation-induced small bowel disease: latest developments and clinical guidance. Ther. Adv. Chronic Dis. 5(1), 15–29 (2014).
  MedlineGoogle Scholar
• 101. Wedlake LJ, Shaw C, Whelan K, Andreyev HJ. Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment. Pharmacol. Ther. 37(11), 1046–1056 (2013).
  Medline CASGoogle Scholar
• 102. Ciorba MA, Riehl TE, Rao MS et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 61(6), 829–838 (2012).
  Medline CASGoogle Scholar
• 103. Liu Q, Nobaek S, Adawi D et al. Administration of Lactobacillus plantarum 299v reduces side-effects of external radiation on colon anastomotic healing in an experimental model. Colorectal Dis. 3(4), 245–252 (2001).
  Medline CASGoogle Scholar
• 104. Delia P, Sansotta G, Donato V et al. Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience. Dig. Liver Dis. 34(Suppl. 2), S84–S86 (2002).
  MedlineGoogle Scholar
• 105. Delia P, Sansotta G, Donato V et al. Use of probiotics for prevention of radiation-induced diarrhea. World J. Gastroenterol. 13(6), 912–915 (2007).
  Medline CASGoogle Scholar
• 106. Henson CC, Burden S, Davidson SE, Lal S. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy. Cochrane Database Syst. Rev. doi:10.1002/14651858.CD009896.pub2 (11), Cd009896 (2013).
  MedlineGoogle Scholar
• 107. Murphy J, Stacey D, Crook J, Thompson B, Panetta D. Testing control of radiation-induced diarrhea with a psyllium bulking agent: a pilot study. Can. Oncol. Nurs. J. 10(3), 96–100 (2000).
  Medline CASGoogle Scholar